Annual Cash & Cash Equivalents
$74.08 M
-$22.18 M-23.04%
December 31, 2023
Summary
- As of February 7, 2025, HROW annual cash & cash equivalents is $74.08 million, with the most recent change of -$22.18 million (-23.04%) on December 31, 2023.
- During the last 3 years, HROW annual cash & cash equivalents has risen by +$69.98 million (+1706.51%).
- HROW annual cash & cash equivalents is now -23.04% below its all-time high of $96.27 million, reached on December 31, 2022.
Performance
HROW Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$72.60 M
+$1.63 M+2.30%
September 30, 2024
Summary
- As of February 7, 2025, HROW quarterly cash and cash equivalents is $72.60 million, with the most recent change of +$1.63 million (+2.30%) on September 30, 2024.
- Over the past year, HROW quarterly cash and cash equivalents has increased by +$6.99 million (+10.66%).
- HROW quarterly cash and cash equivalents is now -24.59% below its all-time high of $96.27 million, reached on December 31, 2022.
Performance
HROW Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
HROW Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -23.0% | +10.7% |
3 y3 years | +1706.5% | +25.9% |
5 y5 years | +1016.1% | +1213.6% |
HROW Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -23.0% | +75.7% | -24.6% | +277.2% |
5 y | 5-year | -23.0% | +1706.5% | -24.6% | +1760.6% |
alltime | all time | -23.0% | >+9999.0% | -24.6% | >+9999.0% |
Harrow Health Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $72.60 M(+2.3%) |
Jun 2024 | - | $70.97 M(+3.5%) |
Mar 2024 | - | $68.54 M(-7.5%) |
Dec 2023 | $74.08 M(-23.0%) | $74.08 M(+12.9%) |
Sep 2023 | - | $65.61 M(+188.3%) |
Jun 2023 | - | $22.75 M(+18.2%) |
Mar 2023 | - | $19.25 M(-80.0%) |
Dec 2022 | $96.27 M(+128.3%) | $96.27 M(+114.1%) |
Sep 2022 | - | $44.96 M(-3.2%) |
Jun 2022 | - | $46.44 M(+10.7%) |
Mar 2022 | - | $41.95 M(-0.5%) |
Dec 2021 | $42.17 M(+928.2%) | $42.17 M(-26.9%) |
Sep 2021 | - | $57.66 M(-20.6%) |
Jun 2021 | - | $72.65 M(+1052.5%) |
Mar 2021 | - | $6.30 M(+53.7%) |
Dec 2020 | $4.10 M(-13.6%) | $4.10 M(-25.8%) |
Sep 2020 | - | $5.53 M(+41.6%) |
Jun 2020 | - | $3.90 M(-0.6%) |
Mar 2020 | - | $3.92 M(-17.4%) |
Dec 2019 | $4.75 M(-28.5%) | $4.75 M(+38.4%) |
Sep 2019 | - | $3.43 M(-14.1%) |
Jun 2019 | - | $3.99 M(-6.4%) |
Mar 2019 | - | $4.26 M(-35.7%) |
Dec 2018 | $6.64 M(+65.2%) | $6.64 M(+5.1%) |
Sep 2018 | - | $6.32 M(+51.4%) |
Jun 2018 | - | $4.17 M(+54.9%) |
Mar 2018 | - | $2.69 M(-33.0%) |
Dec 2017 | $4.02 M(-54.6%) | $4.02 M(+3.9%) |
Sep 2017 | - | $3.87 M(-7.2%) |
Jun 2017 | - | $4.17 M(-43.7%) |
Mar 2017 | - | $7.40 M(-16.5%) |
Dec 2016 | $8.85 M(+229.7%) | $8.85 M(+274.8%) |
Sep 2016 | - | $2.36 M(-56.6%) |
Jun 2016 | - | $5.44 M(-54.0%) |
Mar 2016 | - | $11.82 M(+340.3%) |
Dec 2015 | $2.69 M | $2.69 M(-59.0%) |
Sep 2015 | - | $6.56 M(-34.8%) |
Jun 2015 | - | $10.05 M(+246.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2015 | - | $2.90 M(-64.7%) |
Dec 2014 | $8.21 M(-47.3%) | $8.21 M(-20.8%) |
Sep 2014 | - | $10.36 M(-14.4%) |
Jun 2014 | - | $12.10 M(-14.8%) |
Mar 2014 | - | $14.20 M(-8.8%) |
Dec 2013 | $15.58 M(+55.2%) | $15.58 M(-7.4%) |
Sep 2013 | - | $16.83 M(-6.4%) |
Jun 2013 | - | $17.97 M(-5.3%) |
Mar 2013 | - | $18.98 M(+89.1%) |
Dec 2012 | $10.04 M(+6764.3%) | $10.04 M(-8.7%) |
Sep 2012 | - | $10.99 M(+42.4%) |
Jun 2012 | - | $7.72 M(+5160.6%) |
Mar 2012 | - | $146.70 K(+0.3%) |
Dec 2011 | $146.20 K(-49.8%) | $146.20 K(+6545.5%) |
Sep 2011 | - | $2200.00(-60.7%) |
Jun 2011 | - | $5600.00(-92.1%) |
Mar 2011 | - | $70.90 K(-75.7%) |
Dec 2010 | $291.50 K(-81.7%) | $291.50 K(-37.6%) |
Sep 2010 | - | $467.30 K(-55.2%) |
Jun 2010 | - | $1.04 M(+9.5%) |
Mar 2010 | - | $951.90 K(-40.1%) |
Dec 2009 | $1.59 M(-68.9%) | $1.59 M(-20.5%) |
Sep 2009 | - | $2.00 M(-31.1%) |
Jun 2009 | - | $2.90 M(-30.8%) |
Mar 2009 | - | $4.19 M(-18.0%) |
Dec 2008 | $5.11 M(+37.9%) | $5.11 M(-11.5%) |
Sep 2008 | - | $5.78 M(-13.9%) |
Jun 2008 | - | $6.71 M(+96.9%) |
Mar 2008 | - | $3.41 M(-8.0%) |
Dec 2007 | $3.71 M(>+9900.0%) | $3.71 M(-13.8%) |
Sep 2007 | - | $4.30 M(>+9900.0%) |
Aug 2007 | - | $14.30 K(-15.9%) |
May 2007 | - | $17.00 K(-38.0%) |
May 2007 | $17.00 K(-57.4%) | - |
Feb 2007 | - | $27.40 K(0.0%) |
Nov 2006 | - | $27.40 K(-3.9%) |
Aug 2006 | - | $28.50 K |
May 2006 | $39.90 K | - |
FAQ
- What is Harrow Health annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Harrow Health?
- What is Harrow Health annual cash & cash equivalents year-on-year change?
- What is Harrow Health quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Harrow Health?
- What is Harrow Health quarterly cash and cash equivalents year-on-year change?
What is Harrow Health annual cash & cash equivalents?
The current annual cash & cash equivalents of HROW is $74.08 M
What is the all time high annual cash & cash equivalents for Harrow Health?
Harrow Health all-time high annual cash & cash equivalents is $96.27 M
What is Harrow Health annual cash & cash equivalents year-on-year change?
Over the past year, HROW annual cash & cash equivalents has changed by -$22.18 M (-23.04%)
What is Harrow Health quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HROW is $72.60 M
What is the all time high quarterly cash and cash equivalents for Harrow Health?
Harrow Health all-time high quarterly cash and cash equivalents is $96.27 M
What is Harrow Health quarterly cash and cash equivalents year-on-year change?
Over the past year, HROW quarterly cash and cash equivalents has changed by +$6.99 M (+10.66%)